Correlation of West Nile virus incidence in donated blood with West Nile neuroinvasive disease rates, United States, 2010–2012

Emerging Infectious Diseases

Volumn 23, Issue 2, 2017, Pages 212-219

  Betsem, Edouard ^a,b,c   Kaidarova, Zhanna ^c   Stramer, Susan L ^d   Shaz, Beth ^e   Sayers, Merlyn ^f,g   LeParc, German ^h   Custer, Brian ^c,i   Busch, Michael P ^c,i   Murphy, Edward L ^c,i  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Laboratoire Mixte International de Vaccinologie   (Burkina Faso)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d AMERICAN RED CROSS   (United States)

^e NEW YORK BLOOD CENTER   (United States)

^f Carter BloodCare   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h OneBlood Inc   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WEST NILE VACCINE; VIRUS RNA;

ADULT; ARTICLE; BLOOD DONOR; DISEASE SURVEILLANCE; FEMALE; HUMAN; INFECTION RATE; MALE; NONHUMAN; PATHOGENICITY; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; RISK FACTOR; SEASONAL VARIATION; UNITED STATES; WEST NILE VIRUS; FACTUAL DATABASE; GENETICS; HEALTH SURVEY; HISTORY; INCIDENCE; MEDICAL GEOGRAPHY; SEASON; SPATIOTEMPORAL ANALYSIS; TRANSMISSION; VIROLOGY; WEST NILE FEVER;

BLOOD DONORS; DATABASES, FACTUAL; GEOGRAPHY, MEDICAL; HISTORY, 21ST CENTURY; HUMANS; INCIDENCE; POPULATION SURVEILLANCE; RNA, VIRAL; SEASONS; SPATIO-TEMPORAL ANALYSIS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 85009997105     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2302.161058     Document Type: Article

References (42)

1. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med. 1940;20:471-2.
2. Petersen LR, Hayes EB. Westward ho?-The spread of West Nile virus. N Engl J Med. 2004;351:2257-9. http://dx.doi.org/10.1056/NEJMp048261
3. Centers for Disease Control and Prevention (CDC). Outbreak of West Nile-like viral encephalitis-New York, 1999. MMWR Morb Mortal Wkly Rep. 1999;48:845-9.
4. Gea-Banacloche J, Johnson RT, Bagic A, Butman JA, Murray PR, Agrawal AG. West Nile virus: pathogenesis and therapeutic options. Ann Intern Med. 2004;140:545-53. http://dx.doi.org/10.7326/0003-4819-140-7-200404060-00015
5. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-4. http://dx.doi.org/10.1016/S0140-6736(01)05480-0
6. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med. 2004;141:360-5. http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00010
7. Petersen LR, Carson PJ, Biggerstaff BJ, Custer B, Borchardt SM, Busch MP. Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol Infect. 2013;141:591-5. http://dx.doi.org/10.1017/S0950268812001070
8. Centers for Disease Control and Prevention. West Nile virus disease cases reported to CDC by state, 1999-2013 [cited 2016 Sep 1]. http://www.cdc.gov/westnile/resources/pdfs/cummulative/99_2013_cummulativeHumanCases.pdf
9. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395-402. http://dx.doi.org/10.3201/eid1205.051287
10. Biggerstaff BJ, Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion. 2002;42:1019-26. http://dx.doi.org/10.1046/j.1537-2995.2002.00167.x
11. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al.; West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349:1236-45. http://dx.doi.org/10.1056/NEJMoa030969
12. Harrington T, Kuehnert MJ, Kamel H, Lanciotti RS, Hand S, Currier M, et al. West Nile virus infection transmitted by blood transfusion. Transfusion. 2003;43:1018-22. http://dx.doi.org/10.1046/j.1537-2995.2003.00481.x
13. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med. 2003;349:1205-6. http://dx.doi.org/10.1056/NEJMp038138
14. Centers for Disease Control and Prevention (CDC). Update: detection of West Nile virus in blood donations-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:916-9.
15. Liu A, Lee V, Galusha D, Slade MD, Diuk-Wasser M, Andreadis T, et al. Risk factors for human infection with West Nile Virus in Connecticut: a multi-year analysis. Int J Health Geogr. 2009;8:67. http://dx.doi.org/10.1186/1476-072X-8-67
16. Johnson BJ, Sukhdeo MV. Drought-induced amplification of local and regional West Nile virus infection rates in New Jersey. J Med Entomol. 2013;50:195-204. http://dx.doi.org/10.1603/ME12035
17. Dodd RY, Foster GA, Stramer SL. Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfus Med Rev. 2015;29:153-61. http://dx.doi.org/10.1016/j.tmrv.2015.03.001
18. Centers for Disease Control and Prevention. West Nile virus. Final annual maps and data for 1999-2014 [cited 2016 Feb 24]. http://www.cdc.gov/westnile/statsMaps/finalMapsData/index.html
19. AABB. West Nile Virus Biovigilance Network. 2016 [cited 2016 Sep 1]. http://www.aabb.org/research/hemovigilance/Pages/wnv.aspx
20. Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, et al.; NHLBI Retrovirus Epidemiology Study (REDS). The 2003 West Nile virus United States epidemic: the America’s Blood Centers experience. Transfusion. 2005;45:469-79. http://dx.doi.org/10.1111/j.0041-1132.2005.04315.x
21. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005;353:460-7. http://dx.doi.org/10.1056/NEJMoa044029
22. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451-9. http://dx.doi.org/10.1056/NEJMoa044333
23. Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, et al. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making. Transfusion. 2004;44:1547-54. http://dx.doi.org/10.1111/j.0041-1132.2004.04227.x
24. Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, et al. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion. 2005;45:492-9.
25. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010;202:1354-61. http://dx.doi.org/10.1086/656602
26. AABB. Association bulletin no. 08-03. West Nile virus-revised recommendations for triggering individual donation nucleic acid testing and use of communication plans [cited 2016 Sep 1]. http://www.cdph.ca.gov/programs/lfs/Documents/AABB%20WNV%2004-08.pdf
27. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion. 2009;49:278-88. http://dx.doi.org/10.1111/j.1537-2995.2008.01952.x
28. Orton SL, Stramer SL, Dodd RY. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors. Transfusion. 2006;46:272-7. http://dx.doi.org/10.1111/j.1537-2995.2006.00710.x
29. Cervantes DT, Chen S, Sutor LJ, Stonecipher S, Janoski N, Wright DJ, et al. West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012. Emerg Infect Dis. 2015;21:681-3. http://dx.doi.org/10.3201/eid2104.141178
30. Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, et al. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Transfusion. 2009;49:1160-70. http://dx.doi.org/10.1111/j.1537-2995.2009.02127.x
31. United States Census Bureau. US population estimates. 2012 [cited 2012 Jun 15]. http://www.census.gov
32. Dann RS, Koch GG. Review and evaluation of methods for computing confidence intervals for the ratio of two proportions and considerations for non-inferiority clinical trials. J Biopharm Stat. 2004;15:85-107. http://dx.doi.org/10.1081/BIP-200040844
33. Francis RO, Strauss D, Williams JD, Whaley S, Shaz BH. West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic. Transfusion. 2012;52:2664-70. http://dx.doi.org/10.1111/j.1537-2995.2012.03639.x
34. Petersen LR, Fischer M. Unpredictable and difficult to control—the adolescence of West Nile virus. N Engl J Med. 2012;367:1281-4. http://dx.doi.org/10.1056/NEJMp1210537
35. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA. 2003;290:524-8. http://dx.doi.org/10.1001/jama.290.4.524
36. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania. Lancet. 1998; 352:767-71. http://dx.doi.org/10.1016/S0140-6736(98)03538-7
37. Pybus OG, Suchard MA, Lemey P, Bernardin FJ, Rambaut A, Crawford FW, et al. Unifying the spatial epidemiology and molecular evolution of emerging epidemics. Proc Natl Acad Sci U S A. 2012;109:15066-71. http://dx.doi.org/10.1073/pnas.1206598109
38. Mann BR, McMullen AR, Swetnam DM, Salvato V, Reyna M, Guzman H, et al. Continued evolution of West Nile virus, Houston, Texas, USA, 2002-2012. Emerg Infect Dis. 2013;19:1418-27. http://dx.doi.org/10.3201/eid1909.130377
39. McMullen AR, Albayrak H, May FJ, Davis CT, Beasley DW, Barrett AD. Molecular evolution of lineage 2 West Nile virus. J Gen Virol. 2013;94:318-25. http://dx.doi.org/10.1099/vir.0.046888-0
40. Añez G, Grinev A, Chancey C, Ball C, Akolkar N, Land KJ, et al. Evolutionary dynamics of West Nile virus in the United States, 1999-2011: phylogeny, selection pressure and evolutionary time-scale analysis. PLoS Negl Trop Dis. 2013;7:e2245. http://dx.doi.org/10.1371/journal.pntd.0002245
41. Bakonyi T, Ferenczi E, Erdélyi K, Kutasi O, Csörgő T, Seidel B, et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008/2009. Vet Microbiol. 2013;165:61-70. http://dx.doi.org/10.1016/j.vetmic.2013.03.005
42. Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310:308-15. http://dx.doi.org/10.1001/jama.2013.8042